Saturday, 5 September 2026European Markets

SALMONES CAMANCHAC And SIPEF Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(VIANEWS) - SALMONES CAMANCHAC (SACAM.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Consumer Defensive sector.

Financial Asset Price Forward Dividend Yield Return on Equity
SALMONES CAMANCHAC (SACAM.OL) kr39.20 9.13% 15.89%
SIPEF (SIP.BR) €55.10 5.51% 9.39%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. SALMONES CAMANCHAC (SACAM.OL)

9.13% Forward Dividend Yield and 15.89% Return On Equity

Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic and Coho salmon products in various formats, such as whole, fillet, portion, and other products including bits and pieces, harasu, and scrape meat. It also exports its products. The company was incorporated in 2009 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A. is a subsidiary of Compañía Pesquera Camanchaca S.A.

Earnings Per Share

As for profitability, SALMONES CAMANCHAC has a trailing twelve months EPS of kr4.72.

PE Ratio

SALMONES CAMANCHAC has a trailing twelve months price to earnings ratio of 8.31. Meaning, the purchaser of the share is investing kr8.31 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.89%.

Sales Growth

SALMONES CAMANCHAC's sales growth is negative 89.4% for the ongoing quarter and negative 89.9% for the next.

Volume

Today's last reported volume for SALMONES CAMANCHAC is 100 which is 94.77% below its average volume of 1913.

Revenue Growth

Year-on-year quarterly revenue growth declined by 34.9%, now sitting on 371.78M for the twelve trailing months.

More news about SALMONES CAMANCHAC.

2. SIPEF (SIP.BR)

5.51% Forward Dividend Yield and 9.39% Return On Equity

Sipef NV operates as an agro-industrial company. It operates through Palm, Rubber, Tea, and Bananas and Plants segments. The company offers crude palm oil, palm kernels, and palm kernel oil; ribbed smoked sheets, and scraps and lumps; cut, tear, and curl tea; and bananas and plants from Ivory Coast. It has operations in Indonesia, Papua New Guinea, Ivory Coast, Singapore, Europe, and internationally. The company was incorporated in 1919 and is headquartered in Schoten, Belgium.

Earnings Per Share

As for profitability, SIPEF has a trailing twelve months EPS of €6.7.

PE Ratio

SIPEF has a trailing twelve months price to earnings ratio of 8.22. Meaning, the purchaser of the share is investing €8.22 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.39%.

More news about SIPEF.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com